TetraLogic Announces Termination of Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TetraLogic Pharma (TLOG) to Resume Trading at 2:30
May 6, 2015 2:28 PM EDTTetraLogic Pharma (NASDAQ: TLOG) to Resume Trading at 2:30
... MoreTetraLogic Pharma (TLOG) Terminates Common Stock Offering
May 6, 2015 2:26 PM EDTTetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced termination of the underwriting agreement for and cancellation of its previously announced underwritten public offering of 6.25 million... More
Tetralogic (TLOG) PT Cut to $7 at Needham & Company After Halting Study; Maintains 'Buy'
May 6, 2015 2:08 PM EDTNeedham & Company analyst Chad Messer cut his price target on Tetralogic Pharmaceuticals (NASDAQ: TLOG) to $7.00 (from $10.00) after the comapny announced that it will temporarily halt enrollment multiple ascending dose chronic hepatitis B (HBV) trial of birinapant. However, the firm maintained a Buy... More
